Patients suffering from chronic plantar fasciitis now have a new weapon against this debilitating foot ailment, according to research presented at the Society of Interventional Radiology's Annual Scientific Meeting.

At one time, many children born with congenital heart disease (CHD) suffered from issues that carried fatal prognoses. Thanks to technological advancements in the past 30 to 40 years, Elizabeth Adams, M.D., of Penn State Hershey Children's Heart Group, can predict that a child born today has a 90 percent chance of living to adulthood, even with severe CHD.

The U.S. Food and Drug Administration (FDA) approved the VenaSeal closure system to permanently treat varicose veins of the legs by sealing the affected superficial veins using an adhesive agent.

Point of Care Anticoagulation software (PCDS AC) optimizes delivery of anticoagulation (AC) drugs and reduces adverse events associated with anticoagulation therapy.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now